PAYCOR HCM INC (PYCR)

US70435P1021 - Common Stock

14.03  +0.04 (+0.29%)

After market: 14.03 0 (0%)

Fundamental Rating

4

Overall PYCR gets a fundamental rating of 4 out of 10. We evaluated PYCR against 82 industry peers in the Professional Services industry. The financial health of PYCR is average, but there are quite some concerns on its profitability. PYCR shows excellent growth, but is valued quite expensive already.



2

1. Profitability

1.1 Basic Checks

PYCR had positive earnings in the past year.
PYCR had a positive operating cash flow in the past year.
In the past 5 years PYCR always reported negative net income.
PYCR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of PYCR (-2.41%) is worse than 74.07% of its industry peers.
The Return On Equity of PYCR (-5.42%) is worse than 72.84% of its industry peers.
Industry RankSector Rank
ROA -2.41%
ROE -5.42%
ROIC N/A
ROA(3y)-4.1%
ROA(5y)-4.33%
ROE(3y)-9.22%
ROE(5y)-9.41%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of PYCR (66.09%) is better than 81.48% of its industry peers.
PYCR's Gross Margin has improved in the last couple of years.
PYCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.84%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

PYCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PYCR has been increased compared to 1 year ago.
PYCR has a better debt/assets ratio than last year.

2.2 Solvency

PYCR has an Altman-Z score of 0.86. This is a bad value and indicates that PYCR is not financially healthy and even has some risk of bankruptcy.
PYCR's Altman-Z score of 0.86 is on the low side compared to the rest of the industry. PYCR is outperformed by 75.31% of its industry peers.
There is no outstanding debt for PYCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.86
ROIC/WACCN/A
WACC9.02%

2.3 Liquidity

PYCR has a Current Ratio of 1.08. This is a normal value and indicates that PYCR is financially healthy and should not expect problems in meeting its short term obligations.
PYCR's Current ratio of 1.08 is on the low side compared to the rest of the industry. PYCR is outperformed by 72.84% of its industry peers.
A Quick Ratio of 1.08 indicates that PYCR should not have too much problems paying its short term obligations.
PYCR has a worse Quick ratio (1.08) than 70.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.29% over the past year.
Looking at the last year, PYCR shows a very strong growth in Revenue. The Revenue has grown by 20.33%.
PYCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.01% yearly.
EPS 1Y (TTM)34.29%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q16.67%
Revenue 1Y (TTM)20.33%
Revenue growth 3Y19.01%
Revenue growth 5YN/A
Revenue growth Q2Q15.81%

3.2 Future

PYCR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.93% yearly.
Based on estimates for the next years, PYCR will show a very strong growth in Revenue. The Revenue will grow by 21.43% on average per year.
EPS Next Y22.68%
EPS Next 2Y19.85%
EPS Next 3Y17.46%
EPS Next 5Y26.94%
Revenue Next Year19.08%
Revenue Next 2Y17.66%
Revenue Next 3Y17.13%
Revenue Next 5Y21.43%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.85, the valuation of PYCR can be described as expensive.
PYCR's Price/Earnings ratio is a bit more expensive when compared to the industry. PYCR is more expensive than 62.96% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.15. PYCR is around the same levels.
With a Price/Forward Earnings ratio of 25.05, PYCR can be considered very expensive at the moment.
PYCR's Price/Forward Earnings is on the same level as the industry average.
PYCR's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 20.20.
Industry RankSector Rank
PE 29.85
Fwd PE 25.05

4.2 Price Multiples

PYCR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PYCR is more expensive than 75.31% of the companies in the same industry.
PYCR's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PYCR is more expensive than 71.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 213.9
EV/EBITDA 33.21

4.3 Compensation for Growth

PYCR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PYCR's earnings are expected to grow with 17.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.32
PEG (5Y)N/A
EPS Next 2Y19.85%
EPS Next 3Y17.46%

0

5. Dividend

5.1 Amount

PYCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PAYCOR HCM INC

NASDAQ:PYCR (5/17/2024, 7:22:02 PM)

After market: 14.03 0 (0%)

14.03

+0.04 (+0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.50B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 29.85
Fwd PE 25.05
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.41%
ROE -5.42%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 66.09%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)34.29%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y22.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.33%
Revenue growth 3Y19.01%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y